Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Dalianis

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
International Journal of Oncology|March 29, 2014
Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review)Tina Dalianis
Presse Medicale (Paris, France : 1983)|December 3, 2014
Human papillomavirus (HPV) and oropharyngeal squamous cell carcinomaTina Dalianis
Immunotherapy|July 14, 2012
Immunotherapy for polyomaviruses: opportunities and challengesTina Dalianis
Emerging Infectious Diseases|October 30, 2010
Oropharyngeal cancer epidemic and human papillomavirusTorbjörn Ramqvist, Tina Dalianis
Anticancer Research|March 25, 2010
Lessons from immune responses and vaccines against murine polyomavirus infection and polyomavirus-induced tumours potentially useful for studies on human polyomavirusesTorbjörn Ramqvist, Tina Dalianis
Anticancer Research|April 19, 2011
Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patientsTina Dalianis, Per Ljungman
Anticancer Research|May 28, 2011
An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and preventionTorbjörn Ramqvist, Tina Dalianis
Immunotherapy|July 20, 2010
Immunotherapeutic polyoma and human papilloma virus-like particlesTorbjörn Ramqvist, Tina Dalianis
Seminars in Cancer Biology|June 10, 2009
Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour developmentTorbjörn Ramqvist, Tina Dalianis
Viruses|July 2, 2021
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint InhibitorsPeter L Stern, Tina Dalianis
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
International Journal of Oncology|March 29, 2014
Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review)Tina Dalianis
Presse Medicale (Paris, France : 1983)|December 3, 2014
Human papillomavirus (HPV) and oropharyngeal squamous cell carcinomaTina Dalianis
Immunotherapy|July 14, 2012
Immunotherapy for polyomaviruses: opportunities and challengesTina Dalianis
Emerging Infectious Diseases|October 30, 2010
Oropharyngeal cancer epidemic and human papillomavirusTorbjörn Ramqvist, Tina Dalianis
Anticancer Research|March 25, 2010
Lessons from immune responses and vaccines against murine polyomavirus infection and polyomavirus-induced tumours potentially useful for studies on human polyomavirusesTorbjörn Ramqvist, Tina Dalianis
Anticancer Research|April 19, 2011
Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patientsTina Dalianis, Per Ljungman
Anticancer Research|May 28, 2011
An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and preventionTorbjörn Ramqvist, Tina Dalianis
Immunotherapy|July 20, 2010
Immunotherapeutic polyoma and human papilloma virus-like particlesTorbjörn Ramqvist, Tina Dalianis
Seminars in Cancer Biology|June 10, 2009
Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour developmentTorbjörn Ramqvist, Tina Dalianis
Viruses|July 2, 2021
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint InhibitorsPeter L Stern, Tina Dalianis
Pageof 17